Related Experiment Video
Updated: Aug 6, 2026
Generating CRISPR/Cas9 Mediated Monoallelic Deletions to Study Enhancer Function in Mouse Embryonic Stem Cells
Published on: April 2, 2016
Establishment of heterozygous LMOD2 knockout human embryonic stem cell line (ZZUNEUi022-A-1) using CRISPR/Cas9 system
Chunjin Zhang1, Jing Li1, Yipu Sai1
1Department of Cardiology, The Second Affiliated Hospital of Zhengzhou University. Zhengzhou, Henan 450014, China.
Abstract:
Dilated Cardiomyopathy (DCM), a prevalent form of cardiomyopathy, is characterized by ventricular dilation and systolic dysfunction. Its etiology is intricate, encompassing multiple genetic and environmental elements. The LMOD2 (Leiomodin 2) gene has been demonstrated to be closely associated with the pathogenesis of DCM. In this study, a pure cell line was generated by knocking out the LMOD2 gene, and a DCM cell model was established through induced differentiation, thus providing a powerful experimental approach for further understanding the pathogenesis of DCM. It also provides a potential research orientation for the early diagnosis and individualized treatment of DCM.
Insights
Researchers created a new cell model for Dilated Cardiomyopathy (DCM) by removing the LMOD2 gene. This model aids in understanding DCM causes and developing personalized treatments.
Area of Science:
- Cardiovascular Biology
- Genetic Medicine
- Cellular Pathology
Background:
- Dilated Cardiomyopathy (DCM) is a common heart condition marked by enlarged ventricles and impaired pumping function.
- The exact causes of DCM are complex, involving genetic and environmental factors.
- The Leiomodin 2 (LMOD2) gene is implicated in the development of DCM.
Purpose of the Study:
- To establish a novel cellular model for studying Dilated Cardiomyopathy (DCM).
- To investigate the role of the LMOD2 gene in DCM pathogenesis.
- To provide a platform for exploring early diagnosis and targeted therapies for DCM.
Main Methods:
- Generation of a pure cell line with the LMOD2 gene knocked out.
- Establishment of a DCM cellular model via induced differentiation.
- Utilizing the LMOD2-deficient cell line and DCM model for experimental research.
Main Results:
- Successfully created an LMOD2-knockout cell line.
- Developed a functional DCM cell model.
- The developed model serves as a robust tool for DCM research.
Conclusions:
- The LMOD2-knockout cell line and induced DCM model offer a valuable experimental system.
- This approach facilitates deeper understanding of DCM pathogenesis.
- It opens avenues for future research in early DCM diagnosis and personalized treatment strategies.
